Page 21 - Rob Holtackers

Introduction | 11

9. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging
to identify reversible myocardial dysfunction. N Engl J Med 2000;343(20):1445-1453
10. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to
irreversible injury, infarct age, and contractile function. Circulation 1999;100(19):1992-
2002
11. Simonetti OP, Kim RJ, Fieno DS, et al. An improved MR imaging technique for the
visualization of myocardial infarction. Radiology 2001;218(1):215-223
12. Neilan TG, Coelho-Filho OR, Danik SB, et al. CMR quantification of myocardial scar
provides additive prognostic information in nonischemic cardiomyopathy. JACC
Cardiovasc Imaging 2013;6(9):944-954
13. Bojer AS, Sorensen MH, Vejlstrup N, et al. Distinct non-ischemic myocardial late
gadolinium enhancement lesions in patients with type 2 diabetes. Cardiovasc Diabetol
2020;19(1):184
14. Oakes RS, Badger TJ, Kholmovski EG, et al. Detection and quantification of left atrial
structural remodeling with delayed-enhancement magnetic resonance imaging in patients
with atrial fibrillation. Circulation 2009;119(13):1758-1767
15. Marrouche NF, Wilber D, Hindricks G, et al. Association of atrial tissue fibrosis identified
by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study.
JAMA 2014;311(5):498-506
16. Dickfeld T, Kato R, Zviman M, et al. Characterization of radiofrequency ablation lesions
with gadolinium-enhanced cardiovascular magnetic resonance imaging. J Am Coll Cardiol
2006;47(2):370-378
17. Akoum N, Wilber D, Hindricks G, et al. MRI assessment of ablation-induced scarring in
atrial fibrillation: Analysis from the DECAAF study. J Cardiovasc Electrophysiol
2015;26(5):473-480
18. Fochler F, Yamaguchi T, Kheirkahan M, et al. Late gadolinium enhancement magnetic
resonance imaging guided treatment of post-atrial fibrillation ablation recurrent arrhythmia.
Circ Arrhythm Electrophysiol 2019;12(8):e007174
19. Kirstein B, Morris A, Baher A, et al. Magnetic resonance imaging-guided cryoballoon
ablation for left atrial substrate modification in patients with atrial fibrillation. J Cardiovasc
Electrophysiol 2020;31(7):1587-1594
20. Kramer CM, Barkhausen J, Bucciarelli-Ducci C, et al. Standardized cardiovascular magnetic
resonance imaging (CMR) protocols: 2020 update. J Cardiovasc Magn Reson 2020;22(1):17
21. Mahrholdt H, Wagner A, Judd RM, et al. Assessment of myocardial viability by
cardiovascular magnetic resonance imaging. Eur Heart J 2002;23(8):602-619
22. Kellman P, Arai AE. Cardiac imaging techniques for physicians: late enhancement. J Magn
Reson Imaging 2012;36(3):529-542
23. Look DC, Locker DR. Time Saving in Measurement of NMR and EPR Relaxation Times. Rev
Sci Instrum 1970;41(2):250-251
24. Kim RJ, Shah DJ, Judd RM. How we perform delayed enhancement imaging. J Cardiovasc
Magn Reson 2003;5(3):505-514
25. Setser RM, Chung YC, Weaver JA, et al. Effect of inversion time on delayed-enhancement
magnetic resonance imaging with and without phase-sensitive reconstruction. J Magn
Reson Imaging 2005;21(5):650-655
26. Kellman P, Arai AE, McVeigh ER, et al. Phase-sensitive inversion recovery for detecting
myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med
2002;47(2):372-383